Ocular Therapeutix (OCUL) EBIT Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58,995.00 |
| Dec 31, 2025 | -33,132.00 |
| Sep 30, 2025 | -23,399.00 |
| Jun 30, 2025 | 63,726.00 |
| Mar 31, 2025 | 3,933.00 |
| Dec 31, 2024 | 65,255.00 |
| Sep 30, 2024 | 249,359.00 |
| Jun 30, 2024 | 305,779.00 |
| Mar 31, 2024 | 378,152.00 |
| Dec 31, 2023 | 329,370.00 |
| Sep 30, 2023 | 284,770.00 |
| Jun 30, 2023 | 195,776.00 |
| Mar 31, 2023 | 378,875.00 |
| Dec 31, 2022 | 247,353.00 |
| Sep 30, 2022 | 272,549.00 |
| Jun 30, 2022 | 402,462.00 |
| Mar 31, 2022 | 316,414.00 |
| Dec 31, 2021 | 229,406.00 |
| Sep 30, 2021 | 177,599.00 |
| Jun 30, 2021 | 234,595.00 |
| Mar 31, 2021 | 225,069.00 |
| Dec 31, 2020 | 241,270.00 |
| Sep 30, 2020 | 2.70 Mn |
| Jun 30, 2020 | 95,929.00 |
| Mar 31, 2020 | 235,186.00 |
| Dec 31, 2019 | 54,583.00 |
| Sep 30, 2019 | 194,666.00 |
| Jun 30, 2019 | 280,697.00 |
| Mar 31, 2019 | 2.13 Mn |